Cargando…

Li-Fraumeni syndrome in the setting of re-occurring malignancies after 27 years of remission: a case report

Multiple primary tumors are defined as multiple simultaneous (within 6 months) or heterogeneous tumors. CASE PRESENTATION: Here, the authors present the case of a 58-year-old Saudi female patient with Li-Fraumeni syndrome who has multiple primary tumors. CLINICAL DISCUSSION: The surgical cytoreducti...

Descripción completa

Detalles Bibliográficos
Autores principales: Mousa, Ahmed H., Ibrahim, Abdullatif S., Alsayed, Abdelrahman Waleed, Albukhari, Zain Z., Mogharbel, Ajfan, Alshanberi, Asim M., Albar, Nezar Y.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10289717/
https://www.ncbi.nlm.nih.gov/pubmed/37363471
http://dx.doi.org/10.1097/MS9.0000000000000724
Descripción
Sumario:Multiple primary tumors are defined as multiple simultaneous (within 6 months) or heterogeneous tumors. CASE PRESENTATION: Here, the authors present the case of a 58-year-old Saudi female patient with Li-Fraumeni syndrome who has multiple primary tumors. CLINICAL DISCUSSION: The surgical cytoreduction or ‘debulking’ technique is the main treatment option started in individuals with High Grade Serous Ovarian CanceR. This surgical strategy aims to completely remove all disseminated tumor masses that are present in the patient’s peritoneal cavity on a macroscopic level. CONCLUSION: In conclusion, in our case, she has developed her ovarian cancer 27 years after her breast cancer got treated. This was already stage IIIB to stage IV. If it was not for her incidental discovery of her urinary bladder cancer, which is most likely is a long-term sequel of using cyclophosphamide 27 years ago. Multiple primary tumors are defined as multiple simultaneous (within 6 months) or heterogeneous tumors. Here, the authors present the case of a 58-year-old Saudi female patient with Li-Fraumeni syndrome who has multiple primary tumors. In conclusion, in our case, she has developed her ovarian cancer 27 years after her breast cancer got treated. This was already stage IIIB to stage IV. If it was not for her incidental discovery of her urinary bladder cancer, which is most likely is a long-term sequel of using cyclophosphamide 27 years ago.